Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
November 8, 2022
Patent Application Number
15950042
Date Filed
April 10, 2018
Patent Primary Examiner
The invention provides methods of increasing the efficacy of a T cell therapy in a patient in need thereof. The invention includes a method of conditioning a patient prior to a T cell therapy, wherein the conditioning involves administering a combination of cyclophosphamide and fludarabine.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
